Xintela AB (publ) (STO:XINT)
Sweden
· Delayed Price · Currency is SEK 0.247
-0.018 (-6.79%)
Apr 28, 2026, 5:29 PM CET
Xintela AB Revenue
In the year 2025, Xintela AB had annual revenue of 2.28M SEK, down -45.86%. Xintela AB had revenue of 415.00K in the quarter ending December 31, 2025, a decrease of -61.93%.
Revenue
2.28M
Revenue Growth
-45.86%
P/S Ratio
93.22
Revenue / Employee
175.54K
Employees
13
Market Cap
212.73M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xbrane Biopharma AB | 152.35M |
| Mendus AB | -1.44M |
| Sprint Bioscience AB | 167.39M |
| Bio-Works Technologies AB | 63.11M |
| Diamyd Medical AB | 362.00K |
| Elicera Therapeutics AB | 10.64M |
| Alligator Bioscience AB | 839.00K |